Vitamin D accelerates clinical recovery from tuberculosis: Results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis'

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Salahuddin, Nawal ^a   Ali, Farheen ^b   Hasan, Zahra ^c   Rao, Nisar ^d   Aqeel, Masooma ^b   Mahmood, Faisal ^b  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

^c AGA KHAN UNIVERSITY   (Pakistan)

^d Ojha Institute of Chest Diseases   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; COLECALCIFEROL; GAMMA INTERFERON; MYCOBACTERIUM ANTIGEN; PLACEBO;

ADULT; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DISEASE SEVERITY; DRUG RESPONSE; FEMALE; HUMAN; IMMUNOSTIMULATION; LUNG CAVITY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYCOBACTERIUM TUBERCULOSIS; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; T LYMPHOCYTE ACTIVATION; THORAX RADIOGRAPHY; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; WEIGHT GAIN;

ADOLESCENT; ADULT; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; DIETARY SUPPLEMENTS; FEMALE; HUMANS; INTERFERON-GAMMA; MALE; MYCOBACTERIUM TUBERCULOSIS; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY; VITAMIN D; YOUNG ADULT;

EID: 84872332054     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-22     Document Type: Article

References (31)

1. Liu PT, Stenger S, Tang DH, Modlin RL. Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol 2007, 179(4):2060-2063.
2. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311(5768):1770-1773. 10.1126/science.1123933, 16497887.
3. Gibney KB, MacGregor L, Leder K, Torresi J, Marshall C, Ebeling PR, Biggs BA. Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from sub-Saharan Africa. Clin Infect Dis 2008, 46(3):443-446. 10.1086/525268, 18173355.
4. Sita-Lumsden A, Lapthorn G, Swaminathan R, Milburn HJ. Reactivation of tuberculosis and vitamin D deficiency: the contribution of diet and exposure to sunlight. Thorax 2007, 62(11):1003-1007. 10.1136/thx.2006.070060, 2117124, 17526677.
5. Nnoaham KE, Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol 2008, 37(1):113-119.
6. Talat N, Perry S, Parsonnet J, Dawood G, Hussain R. Vitamin d deficiency and tuberculosis progression. Emerg Infect Dis 2010, 16(5):853-855. 10.3201/eid1605.091693, 2954005, 20409383.
7. Martineau AR, Wilkinson RJ, Wilkinson KA, Newton SM, Kampmann B, Hall BM, Packe GE, Davidson RN, Eldridge SM, Maunsell ZJ, et al. A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med 2007, 176(2):208-213. 10.1164/rccm.200701-007OC, 17463418.
8. Martineau AR, Timms PM, Bothamley GH, Hanifa Y, Islam K, Claxton AP, Packe GE, Moore-Gillon JC, Darmalingam M, Davidson RN, et al. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet 2011, 377(9761):242-250. 10.1016/S0140-6736(10)61889-2, 21215445.
9. Wejse C, Gomes VF, Rabna P, Gustafson P, Aaby P, Lisse IM, Andersen PL, Glerup H, Sodemann M. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 2009, 179(9):843-850. 10.1164/rccm.200804-567OC, 19179490.
10. Wejse C, Gustafson P, Nielsen J, Gomes VF, Aaby P, Andersen PL, Sodemann M. TBscore: Signs and symptoms from tuberculosis patients in a low-resource setting have predictive value and may be used to assess clinical course. Scand J Infect Dis 2008, 40(2):111-120. 10.1080/00365540701558698, 17852907.
11. Seaton A, Seaton D, Leitch AG, Crofton J. Crofton and Douglas's respiratory diseases 1989, Oxford [England]: Blackwell Scientific, 4, 3071550, 21399635.
12. Seaton A, Seaton D, Leitch AG, Crofton J. Crofton and Douglas's respiratory diseases 2000, Malden, Mass: Blackwell Science, 5, 3071550, 21399635.
13. Hasan Z, Rao N, Salahuddin N, Islam M, Ashraf M, Rottenberg ME, Hussain R. M. tuberculosis sonicate induced IFNg, CXCL10 and IL10 can differentiate severity in tuberculosis. Scan J Immunol 75:220-226.
14. Coussens AK, Wilkinson RJ, Hanifa Y, Nikolayevskyy V, Elkington PT, Islam K, Timms PM, Venton TR, Bothamley GH, Packe GE, Darmalingam M, Davidson RN, Milburn HJ, Baker LV, Barker RD, Mein CA, Bhaw-Rosun L, Nuamah R, Young DB, Drobniewski FA, Griffiths CJ. Martineau: Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment.AR. Proc Natl Acad Sci USA 2012, 109(38):15449-15454. 10.1073/pnas.1200072109, 22949664.
15. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon g in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993, 178(6):2249-2254. 10.1084/jem.178.6.2249, 2191274, 7504064.
16. Saunders BM, Britton WJ. Life and death in the granuloma: immunopathology of tuberculosis. Immunol Cell Biol 2007, 85(2):103-111. 10.1038/sj.icb.7100027, 17213830.
17. Dlugovitzky D, Bay ML, Rateni L, Urizar L, Rondelli CF, Largacha C, Farroni MA, Molteni O, Bottasso OA. In vitro synthesis of interferon-g, interleukin-4, transforming growth factor-beta and interleukin-1 beta by peripheral blood mononuclear cells from tuberculosis patients: relationship with the severity of pulmonary involvement. Scand J Immunol 1999, 49(2):210-217. 10.1046/j.1365-3083.1999.00492.x, 10075027.
18. Ulrichs T, Anding R, Kaufmann SH, Munk ME. Numbers of IFN-gamma-producing cells against ESAT-6 increase in tuberculosis patients during chemotherapy. Int J Tuberc Lung Dis 2000, 4(12):1181-1183.
19. Harboe M, Oettinger T, Wiker HG, Rosenkrands I, Andersen P. Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect Immun 1996, 64(1):16-22. 173721, 8557334.
20. Black GF, Weir RE, Chaguluka SD, Warndorff D, Crampin AC, Mwaungulu L, Sichali L, Floyd S, Bliss L, Jarman E, et al. Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-mycobacterium bovis BCG-vaccinated Malawian young adults. Clin Diagn Lab Immunol 2003, 10(4):602-611. 164276, 12853392.
21. Green M. Cod liver oil and tuberculosis. BMJ 2011, 343:d7505. 10.1136/bmj.d7505, 22187324.
22. Nursyam EW, Amin Z, Rumende CM. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones 2006, 38(1):3-5.
23. Moreira-Pfrimer LD, Pedrosa MA, Teixeira L, Lazaretti-Castro M. Treatment of vitamin D deficiency increases lower limb muscle strength in institutionalized older people independently of regular physical activity: a randomized double-blind controlled trial. Ann Nutr Metab 2009, 54(4):291-300. 10.1159/000235874, 19729890.
24. Assimon MM, Salenger PV, El-Fawal HA, Mason DL. Nutritional vitamin D supplementation in haemodialysis: A potential vascular benefit?. Nephrology (Carlton) 2012, 17(3):237-242.
25. Bischoff-Ferrari HA, Dawson-Hughes B, Stocklin E, Sidelnikov E, Willett WC, Orav EJ, Stahelin HB, Wolfram S, Jetter A, Schwager J, et al. Oral supplementation with 25(OH)D(3) versus vitamin D(3) : effects on 25(OH)D levels, lower extremity function, blood pressure and markers of innate immunity. J Bone Miner Res 2011, Epub ahead of print.
26. Eftekhari MH, Akbarzadeh M, Dabbaghmanesh MH, Hasanzadeh J. Impact of treatment with oral calcitriol on glucose indices in type 2 diabetes mellitus patients. Asia Pac J Clin Nutr 20(4):521-526.
27. Morcos MM, Gabr AA, Samuel S, Kamel M, el Baz M, el Beshry M, Michail RR. Vitamin D administration to tuberculous children and its value. Boll Chim Farm 1998, 137(5):157-164.
28. Yamshchikov A, Oladele A, Leonard M, Blumberg H, Ziegler T, Tangpricha V. Vitamin D as adjunctive therapy in refractory pulmonary tuberculosis: a case report. South Med J 2009, 102(6):649-652. 10.1097/SMJ.0b013e3181a5d37e, 2892733, 19434014.
29. Holick MF, Biancuzzo RM, Chen TC, Klein EK, Young A, Bibuld D, Reitz R, Salameh W, Ameri A, Tannenbaum AD. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 2008, 93(3):677-681. 2266966, 18089691.
30. Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet 1998, 351(9105):805-806.
31. Przybelski R, Agrawal S, Krueger D, Engelke JA, Walbrun F, Binkley N. Rapid correction of low vitamin D status in nursing home residents. Osteoporos Int 2008, 19(11):1621-1628. 10.1007/s00198-008-0619-x, 18421544.